Aurora Spine CorpOTCQB:ASAPFView on Canadian Exchange
- LAST PRICE0.2060
- TODAY'S CHANGE (%)-0.0024 (-1.1516%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.1915 / 0.2084
- Day Range
- 52 Week Range
- Volume3,700
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ASAPF |
|---|---|---|
| 01:06 ET | 3700 | 0.206 |
May 13, 2024
Aurora Spine Corporation Announces First Quarter 2024 Financial Results, from 9:09PM ET on Monday May 13, 2024 by Dow Jones
9:09PM ET on Monday May 13, 2024 by Dow JonesAurora Spine Corporation Schedules Conference Call to Update Investors and Discuss First Quarter Fiscal Year 2024 Financial Results, from 7:15AM ET on Monday May 13, 2024 by Dow Jones
7:15AM ET on Monday May 13, 2024 by Dow Jones
Apr 29, 2024
Aurora Spine Corporation Announces Fourth Quarter and Fiscal 2023 Financial Results, from 8:20PM ET on Monday Apr 29, 2024 by Dow Jones
8:20PM ET on Monday Apr 29, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Aurora Spine Corp | 19.8M | 0.0x | --- |
Company Information
Aurora Spine Corporation is a designer and manufacturer of medical devices. The Company is engaged in the development and distribution of minimally invasive, interspinous fusion systems and devices. Its product line includes implants, surgical tools and biologics. Its implants include Cervical Products, Thoraco-Lumbar Products, and SI joint products. The surgical tools include Anterior Disc Prep, Posterior Disc Prep and Compass 4D Retractor System. The biologics consist of ZIP Graft and SiLO Si-Fusion. The Company is focused on DEXA technology, which opens up treatment for osteoporotic patients. It offers DEXA-C Cervical Implants Featuring Visual Density Markers, and DEXA -L Standalone Anterior Lumbar Interbody Fusion System.
Contact Information
- Headquarters
- 20 HOLLY STREET, SUITE 300TORONTO, ON, Canada M4S 3B1
- Phone
- 760-424-2004
- Fax
- ---
Executives
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $19.8M |
|---|---|
Revenue (TTM) | $21.2M |
Shares Outstanding | 70.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.73 |
EPS | $-0.02 |
Book Value | $0.09 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | 0.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -8.25% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
